Back

Multicenter research of bleeding risk between low dose prasugrel and standard dose clopidogrel in patients with coronary artery disease undergoing percutaneous coronary intervention

28 August 2017 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 4 - Acute coronary syndromes Thrombosis and platelets ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Satoshi Tokimasa

Chiba University Hospital, Chiba (Japan)

72 More presentations in this session

Presentation thumbnail
Professor S. Perlini (Pavia, IT)
Abstract
Presentation thumbnail
Doctor V. Bongard (Toulouse, FR)
Abstract
Presentation thumbnail
Doctor Y. Yang (Taoyuan, TW)
Abstract Slides
Presentation thumbnail
Doctor V. Kashtalap (Kemerovo, RU)
Abstract Slides
Presentation thumbnail
Mrs G. Veldre (Tartu, EE)
Abstract Slides

Access the full session

Session thumbnail
Poster session 4 - Acute coronary syndromes

The Event

Event poster

ESC Congress 2017

28 August 2017 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Ticagrelor or prasugrel in patients with acute coronary syndrome and high bleeding risk
27 August 2022
thumbnail
Congress Session
Dual antiplatelet therapy titration after percutaneous coronary intervention: when to escalate, de-escalate, withdraw, and more
28 August 2023
thumbnail
Congress Presentation
Association of ticagrelor vs clopidogrel with net adverse clinical events in patients with mild thrombocytopenia undergoing PCI
2 September 2024
thumbnail
Congress Presentation
Is there an inter-manufacturer difference in generic clopidogrel response?
26 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources